MALAT1 binds to EZH2 and suppresses E-cadherin expression and promotes oxaliplatin-induced EMT and colorectal cancer cell resistance to oxaliplatin (Li et al., 2017) (Table 1). This evidence concerns the gene CDH1 and colorectal cancer.